References
- Yu WL, Cho CC, Lung PF, et al. Ketamine‑related cholangiopathy: A retrospective study on clinical and imaging findings. Abdom Imaging. 2014;39(6):1241–1246. 10.1007/s00261-014-0173-2. PMID: 24934474.
- Nyirenda TJ, Shirazi‑Nejad A, Soliman AS. Persistent ketamine‑induced cholangiopathy: An approach to management. Cureus. 2020;12(11):e11611. 10.7759/cureus.11611. PMID: 33364128; PMCID: PMC7752773.
- Teymouri A, Nasoori H, Fakheri M, Nasiri A. Features of biliary tract diseases in ketamine abusers: A systematic review of case reports. J Med Case Rep. 2024;18(1):84. 10.1186/s13256-024-04421-6. PMID: 38431685; PMCID: PMC10909254
- Waheed HW, Ashraf MR, Sajjad T, et al. Hepatobiliary complications associated with ketamine use: Clinical insights and future directions. Cureus. 2025;17(5):e84974. 10.7759/cureus.84974. PMID: 40585641; PMCID: PMC12203290.
- Shen SH, Wang JH. Imaging diagnosis of ketamine‑induced uropathy. Urol Sci. 2015;26(3):160–164. 10.1016/j.urols.2015.08.001.
- Selby NM, Anderson J, Bungay P, Chesterton LJ, Kolhe NV. Obstructive nephropathy and kidney injury associated with ketamine abuse. NDT Plus. 2008;1(5):310–312. 10.1093/ndtplus/sfn054. Epub 2008 May 21. PMID: 25983920; PMCID: PMC4421282.
- Westerhout C, Vijayananthan A, Kumar G, Chua CB. Radiological features of ketamine‑induced cystitis. EPOS. 2013. 10.1594/ranzcr2013/R-0071.
- Seto WK, Mak SK, Chiu K, et al. Magnetic resonance cholangiogram patterns and clinical profiles of ketamine‑related cholangiopathy in drug users. J Hepatol. 2018;69(1):121–128. 10.1016/j.jhep.2018.03.006. Epub 2018 Mar 16. PMID: 29551711.
- Van Berkel B, Verswijvel G. Hourglass urinary bladder. Abdom Radiol (NY). September 2021; 46(9):4516–4518. 10.1007/s00261-021-03119-3. Epub 2021 May 17. PMID: 33999284.